Tetralogic Pharmaceuticals (TLOG) Target Cut at Needham & Company; 'Buy' Maintained

Go back to Tetralogic Pharmaceuticals (TLOG) Target Cut at Needham & Company; 'Buy' Maintained

TetraLogic Pharma (TLOG) Misses Q4 EPS by 14c

February 26, 2015 4:56 PM EST

TetraLogic Pharma (NASDAQ: TLOG) reported Q4 EPS of ($0.53), $0.14 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on TetraLogic Pharma (TLOG) click here.

... More